Thiagaraj Harish V, Ortiz Thomas C, Devereaux Marvin C, Seaver Ben, Hall Brian, Parker Keith K
Department of Biomedical and Pharmaceutical Sciences (MPH I02), Skaggs School of Pharmacy, The University of Montana, 32 Campus Drive #1552, Missoula, MT 59812-1552, United States.
Neurochem Int. 2007 Jan;50(1):109-18. doi: 10.1016/j.neuint.2006.07.017. Epub 2006 Sep 14.
A bioactive synthetic 11 amino acid peptide probe (P11) was constructed according to the published sequence of the human 5HT1a receptor. The probe was used to enhance understanding of cytoplasmic loop 2/G protein coupling and activation. Additionally, two peptides (P8, P9) from the cytoplasmic loop 3 region were synthesized and studied. These probes were tested in a model system of human 5HT1a receptor stably expressed in Chinese Hamster Ovary cells. In agonist inhibition studies, P11 was active in all three receptor preparations tested: whole cells, membrane bound, and solubilized. In analyses of the membrane bound receptor system, P11 demonstrated uncompetitive inhibition characteristics. When forskolin-stimulated cAMP levels were measured, P11 was inactive in this negatively coupled system. Utilizing a [35S]gamma-S-GTP incorporation assay, P11 was unable to stimulate G protein incorporation of GTP. While P8 and P9 were also broadly active as non-competitive agonist inhibitors, their characteristics differed in the signal transduction system. P8 and P9 did not significantly change forskolin-stimulated cAMP levels. However, P8 increased [35S]gamma-S-GTP incorporation, while P9 decreased incorporation. Thus, P11, a synthetic peptide from the TM3/i2 region of the receptor, provides suggestive evidence that this receptor region is involved in G protein coupling but not activation. On the other hand, P8 and P9 activities suggest that the TM5/i3 region is involved in both coupling to and regulation of G protein activity. The current evidence from these cytoplasmic loop regions is discussed in the overall context of an emerging model for human 5HT1a receptor-G protein interactions.
根据已发表的人类5HT1a受体序列构建了一种具有生物活性的合成11氨基酸肽探针(P11)。该探针用于增进对细胞质环2/G蛋白偶联和激活的理解。此外,还合成并研究了来自细胞质环3区域的两种肽(P8、P9)。这些探针在中国仓鼠卵巢细胞中稳定表达的人类5HT1a受体模型系统中进行了测试。在激动剂抑制研究中,P11在所有测试的三种受体制剂中均有活性:全细胞、膜结合型和可溶型。在膜结合受体系统分析中,P11表现出非竞争性抑制特征。当测量福斯可林刺激的cAMP水平时,P11在这个负偶联系统中无活性。利用[35S]γ-S-GTP掺入试验,P11无法刺激G蛋白掺入GTP。虽然P8和P9作为非竞争性激动剂抑制剂也具有广泛的活性,但它们在信号转导系统中的特征有所不同。P8和P9并没有显著改变福斯可林刺激的cAMP水平。然而,P8增加了[35S]γ-S-GTP掺入,而P9降低了掺入。因此,P11,一种来自受体TM3/i2区域的合成肽,提供了提示性证据,表明该受体区域参与G蛋白偶联但不参与激活。另一方面,P8和P9的活性表明TM5/i3区域参与G蛋白活性的偶联和调节。在人类5HT1a受体-G蛋白相互作用新出现模型的整体背景下讨论了来自这些细胞质环区域的当前证据。